- Home
- HMR vs STRO Comparison
HMR vs STRO Comparison
Compare HMR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMR
- STRO
- Stock Information
- Founded
- HMR 1984
- STRO 2003
- Country
- HMR Greece
- STRO United States
- Employees
- HMR N/A
- STRO N/A
- Industry
- HMR Marine Transportation
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMR Consumer Discretionary
- STRO Health Care
- Exchange
- HMR Nasdaq
- STRO Nasdaq
- Market Cap
- HMR 77.4M
- STRO 76.5M
- IPO Year
- HMR N/A
- STRO 2018
- Fundamental
- Price
- HMR $1.33
- STRO $0.91
- Analyst Decision
- HMR Strong Buy
- STRO Hold
- Analyst Count
- HMR 2
- STRO 7
- Target Price
- HMR $6.00
- STRO $1.97
- AVG Volume (30 Days)
- HMR 150.2K
- STRO 480.6K
- Earning Date
- HMR 11-11-2025
- STRO 11-12-2025
- Dividend Yield
- HMR N/A
- STRO N/A
- EPS Growth
- HMR N/A
- STRO N/A
- EPS
- HMR N/A
- STRO N/A
- Revenue
- HMR $27,657,887.00
- STRO $104,473,000.00
- Revenue This Year
- HMR $36.04
- STRO $65.48
- Revenue Next Year
- HMR $35.83
- STRO N/A
- P/E Ratio
- HMR N/A
- STRO N/A
- Revenue Growth
- HMR N/A
- STRO N/A
- 52 Week Low
- HMR $1.09
- STRO $0.52
- 52 Week High
- HMR $10.04
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- HMR N/A
- STRO 52.61
- Support Level
- HMR N/A
- STRO $0.84
- Resistance Level
- HMR N/A
- STRO $0.95
- Average True Range (ATR)
- HMR 0.00
- STRO 0.06
- MACD
- HMR 0.00
- STRO -0.00
- Stochastic Oscillator
- HMR 0.00
- STRO 65.42
About HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.